USING DECISION MODELING TO DETERMINE COST-EFFECTIVENESS OF PHARMACIST INTERVENTIONS FOR PATIENTS WITH DIABETES

被引：0
|
作者：
Pinto, S. [1 ]
Holl, S. [1 ]
机构：
[1] Univ Toledo, Toledo, OH 43606 USA
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 03期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A66 / A66
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of pharmacist interventions in patients with heart failure in Thailand
    Arunmanakul, Poukwan
    Chaiyakunapruk, Nathorn
    Phrommintikul, Arintaya
    Ruengorn, Chidchanok
    Permsuwan, Unchalee
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2022, 62 (01) : 71 - 78
  • [2] An overview of community pharmacist interventions - Assessing cost-effectiveness and patients' willingness to pay
    Li, SC
    DISEASE MANAGEMENT & HEALTH OUTCOMES, 2003, 11 (02) : 95 - 110
  • [3] Cost-Effectiveness of Pharmacist Care in Diabetes Management: A Systematic Review
    Zhu, Jiejin
    Zhou, Ying
    Wang, Gang
    DIABETES THERAPY, 2024, 15 (01) : 215 - 227
  • [4] Cost-Effectiveness of Pharmacist Care in Diabetes Management: A Systematic Review
    Jiejin Zhu
    Ying Zhou
    Gang Wang
    Diabetes Therapy, 2024, 15 : 61 - 76
  • [5] EVALUATING COST-EFFECTIVENESS OF TREATMENT OPTIONS FOR DIABETES PATIENTS USING SYSTEM DYNAMICS MODELING
    Liu, Shiyong
    Xu, Judy C.
    Liu, Gordon
    Xue, Hong
    Bishai, David
    Wang, Youfa
    2018 WINTER SIMULATION CONFERENCE (WSC), 2018, : 2577 - 2588
  • [6] MANAGEMENT DECISION UTILIZING COST-EFFECTIVENESS MODELING
    NATHAN, I
    IEEE TRANSACTIONS ON RELIABILITY, 1969, R 18 (02) : 54 - &
  • [7] Modeling the Cost-Effectiveness of Interventions to Prevent Plague in Madagascar
    Malloy, Giovanni S. P.
    Brandeau, Margaret L.
    Goldhaber-Fiebert, Jeremy D.
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2021, 6 (02)
  • [8] The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes
    Andrew Lowey
    Sara Moore
    Catherine Norris
    David Wright
    Jonathan Silcock
    Peter Hammond
    Pharmacy World & Science, 2007, 29 : 541 - 545
  • [9] COST-EFFECTIVENESS OF ADDING A PHARMACIST TO THE PRIMARY CARE TEAM FOR THE MANAGEMENT OF TYPE 2 DIABETES PATIENTS
    Yu, J.
    Shah, B.
    Ip, E. J.
    Chan, J.
    VALUE IN HEALTH, 2012, 15 (04) : A181 - A181
  • [10] The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes
    Lowey, Andrew
    Moore, Sara
    Norris, Catherine
    Wright, David
    Silcock, Jonathan
    Hammond, Peter
    PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 541 - 545
12345